Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.30)
# 1,398
Out of 4,479 analysts
118
Total ratings
40.58%
Success rate
-1.63%
Average return
Main Sectors:
28 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $130 → $115 | $105.78 | +8.72% | 7 | Jul 2, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $615 → $600 | $538.23 | +11.48% | 8 | Jul 2, 2024 | |
| OSUR OraSure Technologies | Maintains: In-Line | $5.5 → $4.5 | $4.18 | +7.66% | 2 | Jul 2, 2024 | |
| MTD Mettler-Toledo International | Maintains: In-Line | $1,375 → $1,390 | $1,368.68 | +1.56% | 5 | Jul 2, 2024 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $385 → $425 | $434.66 | -2.22% | 8 | Jul 2, 2024 | |
| EW Edwards Lifesciences | Maintains: In-Line | $89 → $91 | $90.31 | +0.76% | 7 | Jul 2, 2024 | |
| ENOV Enovis | Maintains: Outperform | $70 → $62 | $44.01 | +40.88% | 2 | Jul 2, 2024 | |
| DHR Danaher | Maintains: Outperform | $266 → $260 | $240.54 | +8.09% | 1 | Jul 2, 2024 | |
| BLCO Bausch + Lomb | Maintains: In-Line | $15 → $16 | $14.68 | +5.59% | 5 | Jul 2, 2024 | |
| AZTA Azenta | Maintains: In-Line | $52 → $53 | $51.80 | +2.32% | 4 | Jul 2, 2024 | |
| AVTR Avantor | Maintains: Outperform | $28 → $27 | $20.60 | +31.07% | 10 | Jul 2, 2024 | |
| ABT Abbott Laboratories | Maintains: Outperform | $125 → $120 | $102.99 | +16.52% | 7 | Jul 2, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $45 → $48 | $39.47 | +21.61% | 2 | Jun 25, 2024 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $199 → $191 | $158.66 | +20.39% | 2 | Jun 25, 2024 | |
| ILMN Illumina | Maintains: Outperform | $195 → $175 | $107.12 | +63.37% | 6 | Jun 11, 2024 | |
| TWST Twist Bioscience | Maintains: Outperform | $46 → $50 | $47.30 | +5.71% | 3 | May 3, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $72 → $78 | $76.15 | +2.44% | 3 | Apr 25, 2024 | |
| WAT Waters | Maintains: In-Line | $320 → $340 | $283.55 | +19.91% | 5 | Apr 4, 2024 | |
| SYK Stryker | Maintains: Outperform | $340 → $370 | $332.95 | +11.13% | 3 | Apr 4, 2024 | |
| MLAB Mesa Laboratories | Maintains: Outperform | $124 → $130 | $87.83 | +48.02% | 3 | Apr 4, 2024 | |
| HOLX Hologic | Maintains: In-Line | $76 → $78 | $73.52 | +6.10% | 7 | Apr 4, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $93 → $100 | $76.37 | +30.94% | 2 | Apr 4, 2024 | |
| NVCR NovoCure | Maintains: In-Line | $14 → $15 | $16.94 | -11.45% | 6 | Feb 23, 2024 | |
| RVTY Revvity | Upgrades: Outperform | $88 → $125 | $102.58 | +21.86% | 1 | Jan 4, 2024 | |
| MDT Medtronic | Maintains: Outperform | $88 → $100 | $76.76 | +30.28% | 2 | May 25, 2023 | |
| BAX Baxter International | Maintains: Outperform | $50 → $48 | $32.94 | +45.74% | 4 | Apr 4, 2023 | |
| BDX Becton, Dickinson and Company | Maintains: Outperform | $280 → $275 | $228.42 | +20.39% | 2 | Apr 4, 2023 | |
| HYPR Hyperfine | Initiates: Outperform | $7 | $0.90 | +677.78% | 1 | May 31, 2022 |
Zimmer Biomet Holdings
Jul 2, 2024
Maintains: In-Line
Price Target: $130 → $115
Current: $105.78
Upside: +8.72%
Thermo Fisher
Jul 2, 2024
Maintains: Outperform
Price Target: $615 → $600
Current: $538.23
Upside: +11.48%
OraSure Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $5.5 → $4.5
Current: $4.18
Upside: +7.66%
Mettler-Toledo International
Jul 2, 2024
Maintains: In-Line
Price Target: $1,375 → $1,390
Current: $1,368.68
Upside: +1.56%
Intuitive Surgical
Jul 2, 2024
Maintains: In-Line
Price Target: $385 → $425
Current: $434.66
Upside: -2.22%
Edwards Lifesciences
Jul 2, 2024
Maintains: In-Line
Price Target: $89 → $91
Current: $90.31
Upside: +0.76%
Enovis
Jul 2, 2024
Maintains: Outperform
Price Target: $70 → $62
Current: $44.01
Upside: +40.88%
Danaher
Jul 2, 2024
Maintains: Outperform
Price Target: $266 → $260
Current: $240.54
Upside: +8.09%
Bausch + Lomb
Jul 2, 2024
Maintains: In-Line
Price Target: $15 → $16
Current: $14.68
Upside: +5.59%
Azenta
Jul 2, 2024
Maintains: In-Line
Price Target: $52 → $53
Current: $51.80
Upside: +2.32%
Avantor
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $20.60
Upside: +31.07%
Abbott Laboratories
Jul 2, 2024
Maintains: Outperform
Price Target: $125 → $120
Current: $102.99
Upside: +16.52%
U.S. Bancorp
Jun 25, 2024
Maintains: In-Line
Price Target: $45 → $48
Current: $39.47
Upside: +21.61%
J.B. Hunt Transport Services
Jun 25, 2024
Maintains: Outperform
Price Target: $199 → $191
Current: $158.66
Upside: +20.39%
Illumina
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $107.12
Upside: +63.37%
Twist Bioscience
May 3, 2024
Maintains: Outperform
Price Target: $46 → $50
Current: $47.30
Upside: +5.71%
Boston Scientific
Apr 25, 2024
Maintains: Outperform
Price Target: $72 → $78
Current: $76.15
Upside: +2.44%
Waters
Apr 4, 2024
Maintains: In-Line
Price Target: $320 → $340
Current: $283.55
Upside: +19.91%
Stryker
Apr 4, 2024
Maintains: Outperform
Price Target: $340 → $370
Current: $332.95
Upside: +11.13%
Mesa Laboratories
Apr 4, 2024
Maintains: Outperform
Price Target: $124 → $130
Current: $87.83
Upside: +48.02%
Hologic
Apr 4, 2024
Maintains: In-Line
Price Target: $76 → $78
Current: $73.52
Upside: +6.10%
GE HealthCare Technologies
Apr 4, 2024
Maintains: Outperform
Price Target: $93 → $100
Current: $76.37
Upside: +30.94%
NovoCure
Feb 23, 2024
Maintains: In-Line
Price Target: $14 → $15
Current: $16.94
Upside: -11.45%
Revvity
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $102.58
Upside: +21.86%
Medtronic
May 25, 2023
Maintains: Outperform
Price Target: $88 → $100
Current: $76.76
Upside: +30.28%
Baxter International
Apr 4, 2023
Maintains: Outperform
Price Target: $50 → $48
Current: $32.94
Upside: +45.74%
Becton, Dickinson and Company
Apr 4, 2023
Maintains: Outperform
Price Target: $280 → $275
Current: $228.42
Upside: +20.39%
Hyperfine
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.90
Upside: +677.78%